Skip to main content
Top
Published in: European Journal of Nutrition 2/2022

01-03-2022 | Melanoma | Original Contribution

l-Theanine inhibits melanoma cell growth and migration via regulating expression of the clock gene BMAL1

Authors: Ruyi Zhang, Shuangning Zheng, Zhen Guo, Yanan Wang, Guocui Yang, Zhimin Yin, Lan Luo

Published in: European Journal of Nutrition | Issue 2/2022

Login to get access

Abstract

Purpose

l-Theanine is a unique non-protein amino acid found in green tea, which has been identified as a safe dietary supplement. It has been reported that l-theanine exerts various biological activities. In this study, we explored the anti-cancer effects of l-theanine on melanoma cells.

Methods

A375, B16–F10, and PIG1 cell lines were used in the present study. EdU labeling, TUNEL and Annexin V/PI staining, wound-healing, and transwell migration assay were performed to detect the effects of l-theanine on melanoma cell proliferation, apoptosis, and migration. Brain and muscle Arnt-like protein 1 (BMAL1) was knocked down in melanoma cells to evaluate if l-theanine plays the anti-cancer role through regulating circadian rhythm of melanoma cells. The western blot, qRT-PCR, and dual luciferase assay were performed to explore the mechanism involved in the effects of l-theanine on melanoma cells.

Results

l-Theanine apparently reduced the viability of melanoma cells. Further experiments showed that l-theanine attenuated the proliferation and migration, and promoted apoptosis of melanoma cells. l-Theanine significantly enhanced the expression of BMAL1, a clock gene in melanoma cells. Down-regulation of BMAL1 suppressed the anti-cancer effects of l-theanine on melanoma cells. Further experiments indicated that the p53 transcriptional activity raised by l-theanine was dependent on BMAL1 expression in melanoma cells.

Conclusion

l-Theanine exerts the anti-cancer effect on melanoma cells through attenuating the proliferation and migration, and promoting apoptosis of them, which is dependent on the regulation of the clock gene Bmal1 in melanoma cells.
Appendix
Available only for authorised users
Literature
4.
go back to reference Song F, Amos CI, Lee JE, Lian CG, Fang S, Liu H, MacGregor S, Iles MM, Law MH, Lindeman NI, Montgomery GW, Duffy DL, Cust AE, Jenkins MA, Whiteman DC, Kefford RF, Giles GG, Armstrong BK, Aitken JF, Hopper JL, Brown KM, Martin NG, Mann GJ, Bishop DT, Bishop JA, Geno MELC, Kraft P, Qureshi AA, Kanetsky PA, Hayward NK, Hunter DJ, Wei Q, Han J (2014) Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis 35(9):2097–2101. https://doi.org/10.1093/carcin/bgu140CrossRefPubMedPubMedCentral Song F, Amos CI, Lee JE, Lian CG, Fang S, Liu H, MacGregor S, Iles MM, Law MH, Lindeman NI, Montgomery GW, Duffy DL, Cust AE, Jenkins MA, Whiteman DC, Kefford RF, Giles GG, Armstrong BK, Aitken JF, Hopper JL, Brown KM, Martin NG, Mann GJ, Bishop DT, Bishop JA, Geno MELC, Kraft P, Qureshi AA, Kanetsky PA, Hayward NK, Hunter DJ, Wei Q, Han J (2014) Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis 35(9):2097–2101. https://​doi.​org/​10.​1093/​carcin/​bgu140CrossRefPubMedPubMedCentral
25.
37.
go back to reference Wang Y, Guo SH, Shang XJ, Yu LS, Zhu JW, Zhao A, Zhou YF, An GH, Zhang Q, Ma B (2018) Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response. Acta Pharmacol Sin 39(2):311–327. https://doi.org/10.1038/aps.2017.95CrossRefPubMed Wang Y, Guo SH, Shang XJ, Yu LS, Zhu JW, Zhao A, Zhou YF, An GH, Zhang Q, Ma B (2018) Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response. Acta Pharmacol Sin 39(2):311–327. https://​doi.​org/​10.​1038/​aps.​2017.​95CrossRefPubMed
41.
go back to reference Rastrelli M, Tropea S, Rossi CR, Alaibac M (2014) Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28(6):1005–1011PubMed Rastrelli M, Tropea S, Rossi CR, Alaibac M (2014) Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28(6):1005–1011PubMed
Metadata
Title
l-Theanine inhibits melanoma cell growth and migration via regulating expression of the clock gene BMAL1
Authors
Ruyi Zhang
Shuangning Zheng
Zhen Guo
Yanan Wang
Guocui Yang
Zhimin Yin
Lan Luo
Publication date
01-03-2022
Publisher
Springer Berlin Heidelberg
Keywords
Melanoma
Melanoma
Published in
European Journal of Nutrition / Issue 2/2022
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02677-y

Other articles of this Issue 2/2022

European Journal of Nutrition 2/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.